Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7355 EUR 2.65% Market Closed
Market Cap: 498.9m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Relative Value

The Relative Value of one PHARM stock under the Base Case scenario is 1.8972 EUR. Compared to the current market price of 0.7355 EUR, Pharming Group NV is Undervalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHARM Relative Value
Base Case
1.8972 EUR
Undervaluation 61%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
84
vs Industry
78
Median 3Y
2.4
Median 5Y
3.1
Industry
8.1
Forward
1.8
vs History
vs Industry
3
Median 3Y
-36
Median 5Y
15.4
Industry
23
Forward
-69.7
vs History
vs Industry
6
Median 3Y
-33.6
Median 5Y
11.1
Industry
23.4
vs History
vs Industry
3
Median 3Y
-11.9
Median 5Y
7.5
Industry
27.3
vs History
96
vs Industry
35
Median 3Y
3.4
Median 5Y
3.9
Industry
2.6
vs History
84
vs Industry
69
Median 3Y
2.3
Median 5Y
2.9
Industry
8.1
Forward
1.6
vs History
84
vs Industry
69
Median 3Y
2.5
Median 5Y
3.3
Industry
9.6
vs History
vs Industry
2
Median 3Y
10.8
Median 5Y
10.3
Industry
4.3
Forward
-163.8
vs History
vs Industry
2
Median 3Y
6.4
Median 5Y
10.9
Industry
3.8
Forward
-31
vs History
vs Industry
5
Median 3Y
-32
Median 5Y
10.4
Industry
6
vs History
vs Industry
4
Median 3Y
-30.1
Median 5Y
14.1
Industry
3.8
vs History
96
vs Industry
40
Median 3Y
3.9
Median 5Y
4.5
Industry
4.8

Multiples Across Competitors

PHARM Competitors Multiples
Pharming Group NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
Pharming Group NV
AEX:PHARM
493.6m EUR 1.9 -39 -1 273.5 -28.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 678 545.3 -179 080.5 -217 460.8 -214 979.3
US
Abbvie Inc
NYSE:ABBV
299.8B USD 5.4 59 14.8 22.7
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.6 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.7B USD 11.7 -259.9 26.3 27.6
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 4.1 910.9 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 869.7 -477.1 -519.6 -505.7
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.5 20.7 25.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
86.2B USD 6.2 18.5 17 18.9
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.2 -59.4 -53.6
NL
argenx SE
XBRU:ARGX
34B EUR 18.4 -129.2 -103.9 -75.7
P/E Multiple
Earnings Growth
NL
Pharming Group NV
AEX:PHARM
Average P/E: 211.9
Negative Multiple: -39
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 080.5 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.6
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -259.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -477.1 N/A
AU
CSL Ltd
ASX:CSL
33.5
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.2 N/A
EV/EBITDA Multiple
EBITDA Growth
NL
Pharming Group NV
AEX:PHARM
Average EV/EBITDA: 17.7
Negative Multiple: -1 273.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 460.8 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.3
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -519.6 N/A
AU
CSL Ltd
ASX:CSL
20.7
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -103.9 N/A
EV/EBIT Multiple
EBIT Growth
NL
Pharming Group NV
AEX:PHARM
Average EV/EBIT: 23
Negative Multiple: -28.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 979.3 N/A
US
Abbvie Inc
NYSE:ABBV
22.7
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.6
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
AU
CSL Ltd
ASX:CSL
25.8
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.7 N/A

See Also

Discover More
Back to Top